M Patricia Rivera (University of North Carolina in Chapel Hill, NC, US) provides a valuable update on lung cancer, with a focus on important points the pulmonologist needs to know and the remarkable impact of personalised therapy.
Questions
Part 1
1. What are the most important points the pulmonologist needs to know about the new tumor, node and metastasis (TNM) classification for lung cancer and the revised Fleischner Society guidelines for evaluation and management of incidental pulmonary nodules? (0:10)
2. What web-based resources are available for lung cancer risk assessment and screening? (2:46)
Part 2
1. How is personalised therapy changing the treatment paradigm for lung cancer? (0:10)
2. How has the management of complications related to lung cancer care evolved? (3:56)
Speaker disclosure: M Patricia Rivera serves on advisory panels for AbbVie and Veracyte; she is also an educational speaker for Medscape.
Filmed at the CHEST Annual Meeting, San Antonio, TX, US, October 2018.
